Jianxin Zhao

Evaluation of Epidermal Growth Factor Receptor (EGFR) by Chromogenic In Situ: Hybridization (CISH™) and Immunohistochemistry (IHC) in Archival Gliomas Using Bright-Field Microscopy

Jianhua Tao, R. Wu, A. Marquez, 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Determination of HER2 Gene Amplification by Chromogenic In Situ Hybridization (CISH) in Archival Breast Carcinoma

A. Au, R. Wu, A. Marquez, 2002, Modern Pathology.

Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations.

N. Sneige, Y. Duh, W. Symmans, 2009, American journal of clinical pathology.

Chromogenic In Situ Hybridization Is a Reliable Method for Detecting HER 2 Gene Status in Breast Cancer

N. Sneige, Y. Duh, W. Symmans, 2009 .